SALT LAKE CITY — Identigene last month officially unveiled its Identigene STD test kit, which tests for chlamydia and gonorrhea—two of the more common sexually transmitted diseases—and essentially created a new niche within the growing self-test category.
For the 52 weeks ended Oct. 3, sales of self-test kits—including paternity, drug testing and disease state screening—were up 20.5% to $57.2 million across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.
